Home/CellCentric/Tomasz Knurowski

TK

Tomasz Knurowski

Chief Medical Officer

Therapeutic Areas

Oncology Hematology

CellCentric Pipeline

Drug	Indication	Phase
inobrodib (CCS1477)	Multiple Myeloma	Phase 1/2
inobrodib + Pd (InoPd)	Relapsed/Refractory Multiple Myeloma	Phase 1/2

Leadership Team at CellCentric

Chief Executive Officer & Board Member

Chairman, Investor Director & Board Member

View full CellCentric profile